CIK 0001509745 · Non-accelerated filer<br>Smaller reporting company
CYPHERPUNK TECHNOLOGIES INC.
Sign in to watch- Ticker
- CYPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274412575
- Phone
- 617 252 4343
- Business address
- 47 THORNDIKE STREET, SUITE B1-1, CAMBRIDGE, MA, 02142
- Former names
- LEAP THERAPEUTICS, INC., Dekkun Corp
- 4 Option exercise 10% owner acquired 4,938,801 shares (option exercise)
- 4 Option exercise Chief Investment Officer acquired 4,938,801 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 168,750 shares at $3.92 ($661,500)
- 4 Open-market sale Director sold 50,000 shares at $3.86 ($193,000)
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Other events
- 4 Open-market sale Director sold 20,000 shares at $1.72 ($34,400)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Investment Officer acquired 16,570,852 shares (option exercise)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Option exercise 10% owner acquired 16,570,852 shares (option exercise)
- 8-K Event Material agreement · Unregistered share sale · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K Event Delisting notice
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 32 · 623 filings